Bizarre Patents
User-operated amusement apparatus for kicking the user's buttocks
An apparatus including a user-operated and controlled apparatus for self-infliction of repetitive blows to the user's buttocks by a plurality of elongated arms bearing flexible extensions that rotate under the user's control.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5382596 | Substituted 2-aminotetralins Optically active or racemic compounds represented by the formula ##STR1## where R2 is OA and R3 is selected from the group consisting of H and OA; where A is H or is selected from the group consisting of hydrocarbyl radicals com... | 01/17/1995 |
| 5358971 | Substituted 2-aminotetralins Optically active or racemic compounds are provided having the formula ##STR1## where R2, R3 and R4 are selected from the group consisting of H and OA with the provision that at least one of R2, R3 and... | 10/25/1994 |
| 5314908 | Compounds useful as antiproliferative agents Melatonin compounds are disclosed of the formula ##STR1## where R is hydrogen or C1 to C6 linear or branched alkylene substituted with phenyl; R1 is hydrogen, substituted benzyl, naphthylmethyl or taken together with ... | 05/24/1994 |
| 5310731 | N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents Compounds of the formula ##STR1## are disclosed, wherein R1, represents secondary alkyl; aralkyl; cycloalkyl; heteroaryl substituted alkyl; norbornyl; and substituted secondary alkyl, aralkyl, cycloalkyl, heteroaryl substituted alkyl, ... | 05/10/1994 |
| 5283343 | 2-aryl substituted N-acetyltryptamines and process of preparing such This invention relates to novel melatonin derivatives, such as 2-aryl substituted N-acetyltryptamines, having pharmacological activity, e.g., melatonin antagonist activity, and methods for the synthesis thereof.... | 02/01/1994 |
| 5278150 | 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions The present invention discloses a compound of the formula: ##STR1## where R1 is hydrogen or the group ##STR2## where R3 and R4 are the same or different and are hydrogen, C1 to C12 linear or... | 01/11/1994 |
| 5274003 | Substituted 2-aminotetralins Optically active or racemic compounds are provided having the formula ##STR1## where R2, R3 and R4 are each selected from the group consisting of H and OH with the provision that at least one of R2, R3... | 12/28/1993 |
| 5270346 | Penetration enhancers for transdermal delivery of systemic agents This invention relates to a method for administering systemically active agents, including therapeutic agents, through the skin or mucosal membranes of humans and animals in a transdermal device or formulation comprising topically administering with said ... | 12/14/1993 |
| 5268385 | Method for treating schizophrenia This invention provides a method for treating the symptoms of schizophrenia by interacting selectively with presynaptic dopaminergic D2 receptors without appreciably activating postsynaptic dopamine receptors which comprises administering to a ... | 12/07/1993 |
| 5256398 | Composition for determining viability of tissue A method and composition of determining the viability of tissue in a region of an organism having a vascular circulatory system that supplies blood to said region is disclosed. The composition includes the combination of adenosine or an adenosine antagoni... | 10/26/1993 |
| 5256661 | Substituted 2-aminotetralins and pharmaceutical use Certain novel compounds having the structural formula ##STR1## where R2, R3 and R4 are each selected from the group consisting of H and OA; A is H or is selected from the group consisting of hydrocarbyl radicals, e.g.... | 10/26/1993 |
| 5256647 | Compositions comprising 1-substituted azacycloalkanes This invention provides compositions comprising a physiologically-active agent and a compound having the structural formula ##STR1## wherein X may represent sulfur or two hydrogen atoms; R' is H or a lower alkyl group having 1-4 carbon atoms; m is 2-... | 10/26/1993 |
| 5234945 | Method of producing body weight and food intake using a dopamine D2 receptor agonist This invention provides a method for treating the symptoms of obesity which comprises administering to a human or other mammal suffering from the symptoms of obesity an effective amount of a compound selected from the group consisting of the optically act... | 08/10/1993 |
| 5234959 | Penetration enhancers for transdermal delivery of systemic agents This invention relates to a method for administering systemically active agents including therapeutic agents through the skin or mucosal membranes of humans and animals and into the blood stream in a transdermal device or formulation comprising topically ... | 08/10/1993 |
| 5218113 | N-substituted thiolactams This invention provides compositions comprising a physiologically-active agent and a compound having the structural formula ##STR1## wherein X may represent sulfur or two hydrogen atoms; R' is H or a lower alkyl group having 1-4 carbon atoms; m is 2-... | 06/08/1993 |
| 5206377 | Compounds useful as antiproliferative agents Melatonin compounds are disclosed of the formula ##STR1## where R is hydrogen or C1 to C6 linear or branched alkylene substituted with phenyl; R1 is hydrogen, substituted benzyl, naphthylmethyl or taken together with ... | 04/27/1993 |
| 5204339 | Penetration enhancers for transdermal delivery of systemic agents This invention relates to a method for administering systemically active agents including therapeutic agents through the skin or mucosal membranes of humans and animals in a transdermal device or formulation comprising topically administering with said sy... | 04/20/1993 |
| 5177112 | Substituted 2-aminotetralins Certain novel compounds having the structural formula ##STR1## wherein R2, R3 and R4 are each selected from the group consisting of H and OA; A is H or is selected from the group consisting of hydrocarbyl radicals, e.... | 01/05/1993 |
| 5142044 | Penetration enhancers for transdermal delivery of systemic agents This invention relates to a method for administering systemically active agents including therapeutic agents through the skin or mucosal membranes of humans and animals in a transdermal device or formulation comprising topically administering with said sy... | 08/25/1992 |
| 5140015 | 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents Compounds are disclosed having the formulae: ##STR1## wherein R1 is selected from the group, consisting of radicals represented by the general formulae: ##STR2## wherein Y is selected from the group consisting of lower alkyl, lower ... | 08/18/1992 |
| 5117830 | Method of determining viability of tissue A method and composition for determining the viability of tissue in a region of an organism having a vascular circulatory system that supplies blood to said region including the steps of dilating said vascular circulation system by introducing adenosine o... | 06/02/1992 |
| 5118845 | Penetration enhancer for transdermal delivery of systemic agents This invention relates to a method administering systemically active agents including therapeutic agents through the skin or mucosal membranes of humans and animals in a transdermal device or formulation comprising topically administering with said system... | 06/02/1992 |
| 5118692 | Penetration enhances for transdermal delivery of systemic agents This invention relates to a method for administering systemically active agents including therapeutic agents through the skin or mucosal membranes of humans and animals and into the blood steam in a transdermal device or formulation comprising topically a... | 06/02/1992 |
| 5118676 | Penetration enhancers for transdermal delivery of systemic agents This invention relates to a method for administering systemically active agents including therapeutic agents through the skin or mucosal membranes of humans and animals and into the blood stream in a transdermal device or formulation comprising topically ... | 06/02/1992 |
| 5108991 | Vehicle composition containing 1-substituted azacycloalkan-2-ones Compositions useful for carrying physiologically active agents such as therapeutic agents through skin and other body membranes comprising the agent and an effective, non-toxic amount of a compound having the structural formula ##STR1## wherein ... | 04/28/1992 |
| 5093352 | Antidepressant agents 2-aryl substituted N-acetyl tryptamines are utilized as antidepressant agents.... | 03/03/1992 |
| 5034386 | Methods for administration using 1-substituted azacycloalkanes This invention provides compositions comprising a physiologically-active agent and a compound having the structural formula ##STR1## wherein each X, Y and Z may represent oxygen, sulfur or two hydrogen atoms, provided however that, when Z represents ... | 07/23/1991 |
| 4996226 | Method and compositions for treatment of parkinsonism syndrome in mammels This invention provides a method for treating the symptoms of parkinsonism which comprises administering to a human or other mammal suffering from the symptoms of parkinsonism an effective amount of a compound selected from the group consisting of optical... | 02/26/1991 |
